Additionally, HDFC Securities has assigned an ‘add’ rating to Max Healthcare Institute, Dr. Lal PathLabs, and Metropolis Healthcare, with price targets of ₹900, ₹2,700, and ₹2,010, respectively. The brokerage anticipates that India’s healthcare sector is on track for continuous expansion, driven by factors such as an aging population, a rise […]
Metropolis Healthcare stock price
The brokerage emphasised that the Indian healthcare landscape post pandemic is poised to capitalise on structural tailwinds such as heightened consumer awareness, favorable demographics, rise in lifestyle related diseases, and substantial public sector investments in infrastructure. Also Read: Market Meltdown: Indian stocks lag behind global peers in May – key […]